Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
(MedPage Today) — The phase III trial COURAGE-ALS of investigational reldesemtiv, a fast skeletal troponin activator, did not meet its primary endpoint in amyotrophic lateral sclerosis (ALS), but its findings shed light on ALS clinical research…Source link
